◄Previous: 8.6 Moving the goalposts

# 8.7 References for Reading 1

Fitzpatrick, M. (2004) Chapter 8 ‘The Lancet Paper’ taken from MMR and Autism: What Parents Need to Know, London, Routledge. Copyright © 2004 Michael Fitzpatrick.

Note: Internet sites originally accessed between January and December 2003.

Abbasi, K. (2001) ‘Man, mission, rumpus’, British Medical Journal; 322: p.306.

Afzal, M.A., Osterhaus, A.D.M.E., Cosby, S.L., Jin, L., Beeler, J., Takeuchi, K., Kawashima, H. (2003) ‘Comparative evaluation of measles virus-specific RT-PCR methods through an international collaborative study’, Journal of Medical Virology; 70: pp. 171–6.

Allergy Induced Autism (1999) Statement on Taylor et al. 1999, at http://www.whale.to/vaccines/aia.html.

Aitken, K.J. (2001b) ‘Q&A’ at http://www.singlevaccines.com/ken-aitken1.html.

Arlett, P., Bryan, P. (2001) ‘A response to “MMR: through a glass, darkly” by Drs A.J. Wakefield and S.M. Montgomery and published reviewers’ comments’, Adverse Drug Reactions and Toxicological Review; 20 (1): pp. 37–45.

Bandolier (2002) ‘MMR vaccination’ at http://www.jr2.ox.ac.uk/bandolier/band84/MMR.html.

Brown, D.W.G., Jin, L., Ramsay, M. (2002) ‘Comments on abstract submission’, Infectious Diseases in the News (27 June), London: Public Health Laboratory Service (http://www.phls.org.uk/press).

Calman, K. (1998) ‘MMR vaccine, Crohn's disease and autism’, From the Chief Medical Officer (27 March).

Chen, R.T., DeStefano, F. (1998) ‘Vaccine adverse events: causal or coincidental?’, Lancet; 351: pp.611–12.

Dealler, S. (2001) ‘MMR and toxicology’, Adverse Drug Reactions and Toxicology Review; 20(1): pp.55–7.

Elliman, D., Bedford, H. (2001) ‘MMR vaccine: the continuing saga’, British Medical Journal; 322: pp. 183–4.

Finn, A. (2002) ‘MMR vaccine debate: competing interests need to be declared’ (Letter), British Medical Journal; 324: pp.734–5.

Fitzpatrick, M. (1998) ‘How now mad cow?’ in I. McCalman with B. Penny and M. Cook (eds.), Mad Cows and Modernity: Cross disciplinary reflections on the crisis of Creutzfeldt-Jakob Disease, Humanities Research Centre Monograph Series No. 13, Canberra: Australian National University.

Fletcher, A.P. (2000) ‘Referee 3’ (comments on ‘MMR vaccine: through a glass darkly’ by A.J. Wakefield and S.M. Montgomery) Adverse Drug Reactions and Toxicology Reviews; 19 (4): pp.288–91.

Galambos, L. (1999) ‘A century of innovation in vaccines’, Vaccine; 17: S7–10.

Gallagher, R. (2003) ‘Vaccination undermined’, The Scientist; 17 (22) (17 November): p.6.

Halsey, N.A. et al. (2001) ‘MMR vaccine and autistic spectrum disorder: a report from the new challenges in childhood immunisation conference’, Paediatrics; 107(5): e84.

Horton, R. (2003) Second Opinion: Doctors, diseases and decisions in modern medicine, London: Granta.

Institute of Medicine (2003) Financing Vaccines in the 21st Century: Assuring access and availability, Washington, DC: National Academy of Sciences.

Lindley, K.J., Milla, P.J. (1998) ‘Autism, inflammatory bowel disease, and MMR vaccine’ (Correspondence), Lancet; 351: p.907.

Madsen, K.M., Hvidd, A., Vestergaard, M., Schendel, D., Wohlfart, J., Thorsen, P., Olsen, J., Melbye, M. (2002) ‘A population-based study of MMR vaccine and autism’, New England Journal of Medicine; 347: pp. 1477–82.

Miller, D.L., Madge, N., Diamond, J., Wadsworth, J., Ross, E. (1993) ‘Pertussis immunisation and serious acute neurological illnesses in children’, British Medical Journal; 307: pp.1171–6.

Miller, E., Andrews, N. (2001) ‘Comments on “MMR: through a glass darkly”’ (http://www.phls.co.uk/facts/Vaccination/012201wakefield.htm).

Mills, H. (2002) MMR: The story so far, Private Eye Special Report, London: Private Eye.

Moses, V. (2002) ‘Chewing over GM food’, spiked-online, 5 February, http://www.spiked-online.com/Articles/00000002D3EF.htm.

Moynihan, R., Heath I., Henry D. (2002) ‘Selling Sickness: The pharmaceutical industry and disease mongering’, British Medical Journal; 324:pp.886–91.

MRC (Medical Research Council) (1998) ‘Group concluded no reason for change in MMR vaccine policy’, Press Release Ref: 09/98, London: MRC.

Murch, S., Thomson, M., Walker-Smith, J.A. (1998) ‘Autism, inflammatory bowel disease, and MMR vaccine’ (Correspondence: authors’ reply), Lancet; 351: p.908.

O'Leary, J.J. (2002a) ‘Link found between measles virus and gut abnormalities in children with developmental disorder’ (Press Statement) (see mp.bmjjournals.com/cgi/content/full/54/DC1).

Peltola, H. Patja, A., Leinikki, P., Valle, M., Davidkin, I., Paunio, M. (1998) ‘No evidence for MMR vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study’, Lancet; 351: pp.1327–8.

Phillips, M. (2003) ‘MMR: the truth’, Daily Mail, 11–13 March.

Richmond, P., Goldblatt, D. (1998) ‘Autism, inflammatory bowel disease, and MMR vaccine’ (Correspondence), Lancet; 351: p. 1355.

Shiels, O., Smyth, P., Martin, C., O'Leary, J.J. (2002) ‘Development of an ‘allelic discrimination’ type assay to differentiate between the strain origins of measles virus detected in intestinal tissue of children with ileocolonic lymphonodular hyperplasia and concomitant developmental disorder’. Abstract (No 20) presented at Pathological Society of Great Britain and Ireland (http://www.pathsoc.org.uk/meet/prog.shtml).

Taylor, B., Miller, E., Farrington, C.P., Petropooulos, M.-C., Favot-Mayaud, I., Li, J. Waight, P.A. (1999a) ‘Autism and MMR vaccine: no epidemiological evidence for a causal association’, Lancet; 353: pp.2026–9.

Taylor, B., Miller, R., Farrington, C.P. (1999b) ‘MMR vaccination and autism’, (Correspondence: authors’ reply), Lancet; 354: p.950.

Uhlmann, V., Shiels, O., Wakefield, A.J., O'Leary, J. (2002) ‘Potential viral pathogenic mechanism for new variant IBD’, Journal of Clinical Pathology and Molecular Pathology; 55 (2): pp.84–90.

Wakefield, A.J., Montgomery, S.M. (2000) ‘MMR vaccine: through a glass darkly’, Adverse Drug Reactions and Toxicology Reviews; 19: pp.265–83.

Wakefield, A.J. (2001b) ‘Testimony of Dr Andrew J Wakefield before the Government Reform Committee of the US House of Representatives’, at http://www.unlockingautism.org/testimonies/index.

Wakefield, A.J. (2002b) Visceral, Press release, November, in response to Madsen et al. (2002) at http://www.visceral.org.uk.

Wakefield, A.J., Murch, S.M., Anthony, A., Linnell, J., Casson, D.M., Malik, M., Berelowitz, M., Dhillon, A.P., Thomson, M.A., Harvey, P., Valentine, A., Davies, S.E., Walker-Smith, J.A. (1998) ‘Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children’, Lancet; 351: pp.637–41.

Walker-Smith, J.A. (2003) ‘Enduring Memories: A paediatric gastroenterologist remembers’, London: The Memoir Club.

This completes Reading 1. Please click here to return to the main course.

◄Contents►Next: 9 Reading 2: Communication and miscommunication of risk: understanding UK parents' attitudes to combined MMR vaccination

OpenLearn - The MMR vaccine: Public health, private fears
Except for third party materials and otherwise, this content is made available under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 Licence, full copyright detail can be found in the acknowledgements section. Please see full copyright statement for details.